Telemonitoring data from continuous positive airway pressure (CPAP) devices could be used to screen people with obstructive sleep apnea (OSA) for COVID-19 and other respiratory infections. Cessation or decreased use of CPAP devices was found in patients with COVID-19.
Why this matters ?
Early detection of SARS-CoV-2 infection is essential to reduce disease transmission. This is particularly important in people with OSA, due to the high prevalence of comorbidities and the potential increased risk of transmission due to aerosol dispersion through CPAP devices.
For people with sleep apnea, established telemonitoring programs could potentially be repurposed to screen for respiratory infections such as COVID-19.